Harmony Biosciences Holdings, Inc. (HRMY): Gross Profit
$670.11M
Year ended 2025-12-31
$723.99M
Trailing 12 months to 2026-06-30
+23.7%
3-year compound annual growth
+38.4%
5-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $670.11M | +20.1% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $557.92M | +21.1% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $460.79M | +30.0% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $354.37M | +41.8% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $249.92M | +89.3% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $132.00M | n/m | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | $4.42M | n/a | 2022-02-28, From 2019-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $670.11M | +20.1% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $463.26M | +22.8% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $416.70M | +15.0% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $576.66M | +8.7% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $356.06M | -4.8% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $644.39M | +10.4% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $982.51M | +12.2% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $595.58M | -6.1% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $599.89M | +65.6% |
Compare HRMY, COLL, EBS, PCRX side by side · Screen every company in Pharmaceutical Preparations ↗